175 related articles for article (PubMed ID: 36016357)
1. CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection.
Kedarinath K; Fox CR; Crowgey E; Mazar J; Phelan P; Westmoreland TJ; Alexander KA; Parks GD
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016357
[TBL] [Abstract][Full Text] [Related]
2. The Robust Restriction of Zika Virus by Type-I Interferon in A549 Cells Varies by Viral Lineage and Is Not Determined by IFITM3.
Gobillot TA; Humes D; Sharma A; Kikawa C; Overbaugh J
Viruses; 2020 May; 12(5):. PubMed ID: 32370187
[TBL] [Abstract][Full Text] [Related]
3. The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner.
Mazar J; Brooks JK; Peloquin M; Rosario R; Sutton E; Longo M; Drehner D; Westmoreland TJ
Cancer Res Commun; 2024 Jan; 4(1):65-80. PubMed ID: 38214542
[TBL] [Abstract][Full Text] [Related]
4. Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.
Mazar J; Li Y; Rosado A; Phelan P; Kedarinath K; Parks GD; Alexander KA; Westmoreland TJ
PLoS One; 2018; 13(7):e0200358. PubMed ID: 30044847
[TBL] [Abstract][Full Text] [Related]
5. A CRISPR Activation Screen Identifies Genes That Protect against Zika Virus Infection.
Dukhovny A; Lamkiewicz K; Chen Q; Fricke M; Jabrane-Ferrat N; Marz M; Jung JU; Sklan EH
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142663
[TBL] [Abstract][Full Text] [Related]
6. STAT2-dependent restriction of Zika virus by human macrophages but not dendritic cells.
Yang D; Chu H; Lu G; Shuai H; Wang Y; Hou Y; Zhang X; Huang X; Hu B; Chai Y; Yuen TT; Zhao X; Lee AC; Ye Z; Li C; Chik KK; Zhang AJ; Zhou J; Yuan S; Chan JF
Emerg Microbes Infect; 2021 Dec; 10(1):1024-1037. PubMed ID: 33979266
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
[TBL] [Abstract][Full Text] [Related]
8. Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein.
Chaudhary V; Yuen KS; Chan JF; Chan CP; Wang PH; Cai JP; Zhang S; Liang M; Kok KH; Chan CP; Yuen KY; Jin DY
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468880
[TBL] [Abstract][Full Text] [Related]
9. Zika Virus Production Is Resistant to RNase L Antiviral Activity.
Whelan JN; Li Y; Silverman RH; Weiss SR
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142667
[TBL] [Abstract][Full Text] [Related]
10. Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.
Mladinich MC; Schwedes J; Mackow ER
mBio; 2017 Jul; 8(4):. PubMed ID: 28698279
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection.
Xu H; Cheng M; Chi X; Liu X; Zhou J; Lin T; Yang W
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270223
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Proteomic Analysis of Mosquito C6/36 Cells Reveals Host Proteins Involved in Zika Virus Infection.
Xin QL; Deng CL; Chen X; Wang J; Wang SB; Wang W; Deng F; Zhang B; Xiao G; Zhang LK
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404849
[TBL] [Abstract][Full Text] [Related]
13. STAT5: a Target of Antagonism by Neurotropic Flaviviruses.
Zimmerman MG; Bowen JR; McDonald CE; Young E; Baric RS; Pulendran B; Suthar MS
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534033
[TBL] [Abstract][Full Text] [Related]
14. Interferon stimulated gene 15 promotes Zika virus replication through regulating Jak/STAT and ISGylation pathways.
Wang Y; Ren K; Li S; Yang C; Chen L
Virus Res; 2020 Oct; 287():198087. PubMed ID: 32738280
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Congenital Zika Disease Depend on Timing of Infection and Maternal-Fetal Interferon Action.
Chen J; Liang Y; Yi P; Xu L; Hawkins HK; Rossi SL; Soong L; Cai J; Menon R; Sun J
Cell Rep; 2017 Nov; 21(6):1588-1599. PubMed ID: 29117563
[TBL] [Abstract][Full Text] [Related]
16. 2', 5'-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling Pathway.
Liao X; Xie H; Li S; Ye H; Li S; Ren K; Li Y; Xu M; Lin W; Duan X; Yang C; Chen L
Viruses; 2020 Apr; 12(4):. PubMed ID: 32276512
[TBL] [Abstract][Full Text] [Related]
17. Human Testicular Germ Cells, a Reservoir for Zika Virus, Lack Antiviral Response Upon Zika or Poly(I:C) Exposure.
Kuassivi ON; Abiven H; Satie AP; Cartron M; Mahé D; Aubry F; Mathieu R; Rebours V; Le Tortorec A; Dejucq-Rainsford N
Front Immunol; 2022; 13():909341. PubMed ID: 35784373
[TBL] [Abstract][Full Text] [Related]
18. The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.
Raini SK; Takamatsu Y; Dumre SP; Urata S; Mizukami S; Moi ML; Hayasaka D; Inoue S; Morita K; Ngwe Tun MM
Antiviral Res; 2021 Aug; 192():105121. PubMed ID: 34175321
[TBL] [Abstract][Full Text] [Related]
19. Targeting SUMO Modification of the Non-Structural Protein 5 of Zika Virus as a Host-Targeting Antiviral Strategy.
Zhu Z; Chu H; Wen L; Yuan S; Chik KK; Yuen TT; Yip CC; Wang D; Zhou J; Yin F; Jin DY; Kok KH; Yuen KY; Chan JF
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658479
[TBL] [Abstract][Full Text] [Related]
20. Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids.
Pettke A; Tampere M; Pronk R; Wallner O; Falk A; Warpman Berglund U; Helleday T; Mirazimi A; Puumalainen MR
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
